Shaji Kumar, MD

Shaji Kumar, MD

Professor of Medicine; Consultant in the Division of Hematology, Internal Medicine

Research Focus:
The research of Dr. Shaji Kumar, MD, focuses on development of novel drugs for treatment of myeloma.Dr. Shaji Kumar's research team evaluates the in vitro activity of novel drugs that, based on their mechanisms of action, are likely to have activity in the setting of myeloma. Promising drugs are brought into the clinic through early-stage clinical trials in Phase I or II studies. Dr. Kumar conducts National Institutes of Health-funded research on translation of novel therapeutic targets in multiple myeloma, understanding the mechanism of disease progression from monoclonal gammopathy of undetermined significance to active myeloma, and mechanisms of high risk disease. He also receives funding from the Multiple Myeloma Research Foundation to study the relationship between molecular profiles, treatment regimens for patients with multiple myeloma and outcomes and various clinical trials in relapsed multiple myeloma. He is the Principle Investigator on a large national trial comparing different treatment regimens for newly diagnosed myeloma. In addition to myeloma, his research also encompass related disorders such as light chain amyloidosis.

years treating myeloma: 15

Number of Myeloma Patients Treated Annually: 200-500

Details & contact info

Mayo Clinic

7 Level Skyway
Rochester, MN, United States, 55906

Phone: (507) 284-2511

View Full Physician Bio

View Website

Send a message to Shaji Kumar, MD


Thanks to our Myeloma Crowd Community sponsors:

.                         .       .